FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and to haemostatic wound dressing comprising a non-colloidal porous dressing material and a plurality of fibrinogen-binding peptides immobilised to said non-colloidal porous dressing material, wherein each fibrinogen-binding peptide comprises: an amino acid sequence Gly-Pro-Arg-Xaa (SEQ ID NO: 1) at an amino-terminal end of the peptide, wherein Xaa is any amino acid other than valine; or an amino acid sequence Gly-His-Arg-Xaa (SEQ ID NO: 2) at an amino-terminal end of the peptide, wherein Xaa is any amino acid other than proline. Group of inventions also relates to a kit for formation of a haemostatic wound dressing; methodsfor controlling bleeding, which comprises administering said dressing; method of making a haemostatic wound dressing.
EFFECT: group of inventions provides a synergistic effect in relation to controlling bleeding.
31 cl, 6 ex, 5 dwg
Title |
Year |
Author |
Number |
HEMOSTATIC COMPOSITIONS |
2016 |
- Zbozien Renata
- Nichols Ben
|
RU2744694C2 |
PROCOAGULANT PEPTIDES, THEIR DERIVATIVES AND THEIR APPLICATION |
2012 |
|
RU2635510C2 |
PEPTIDE IMMUNOGENS AND COMPOSITIONS CONTAINING SAID IMMUNOGENS TARGETING MEMBRANE-BOUND IGE FOR TREATING IGE-MEDIATED ALLERGIC DISEASES |
2017 |
- Wang, Chang Yi
- Lin, Feng
- Chen, Jiun Bo
|
RU2769983C2 |
BIOGEL |
2007 |
|
RU2503464C2 |
PEPTIDE IMMUNOGENS TARGETING INTERLEUKIN 6 (IL-6) AND COMPOSITIONS THEREOF FOR IMMUNOTHERAPY OF DISEASES AFFECTED BY IMPAIRED IL-6 REGULATION |
2019 |
- Wang, Chang, Yi
- Lin, Feng
- Chen, Jiun, Bo
- Ding, Shuang
|
RU2780161C1 |
TARGETED THERAPEUTIC LYSOSOMAL ENZYME FUSION PROTEINS AND USES THEREOF |
2013 |
- Aoyagi-Skarber Mika
- Kristianson Tereza Margaret
- Dvorak-Evell Melita
- Vendt Deniel Dzh.
- Long Shinong
- Lebovits Dzhonatan
- Gold Deniel Solomon
|
RU2680581C2 |
IL-31 PEPTIDE IMMUNOGENS AND THEIR COMPOSITIONS FOR THE TREATMENT AND/OR PREVENTION OF ADOPIC DERMATITIS |
2018 |
|
RU2799440C2 |
PEPTIDE IMMUNOGENS FROM C-TERMINAL END OF ALPHA-SYNUCLEIN PROTEIN AND COMPOSITIONS BASED ON THEM FOR TREATMENT OF SYNUCLEONOPATHIES |
2018 |
|
RU2810774C2 |
ANTI-BAG2 ANTIBODY AND METHODS OF TREATING CANCER |
2020 |
- Kim Seong Jin
- Kang Dong Woo
|
RU2815586C2 |
POLYPEPTIDES MODULATING SIGLEC-DEPENDENT IMMUNE RESPONSES |
2017 |
- Kannicht, Christoph
- Winge, Stefan
- Kohla, Guido
- Solecka-Witulska, Barbara
|
RU2776807C2 |